Search
for
Sort by
Research 301–330 of 1000+
- Epidemiology and treatment modalities for the management of benign prostatic hyperplasia
- Androgenetic Alopecia: An Update of Treatment Options
- 5α-Reductase Inhibition Prevents the Luteal Phase Increase in Plasma Allopregnanolone Levels and Mitigates Symptoms in Women with Premenstrual Dysphoric Disorder
- The Rationale for Inhibiting 5α-Reductase Isoenzymes in the Prevention and Treatment of Prostate Cancer
- Frontal fibrosing alopecia: A retrospective review of 19 patients seen at Duke University
- Pharmacological therapy of benign prostatic hyperplasia/lower urinary tract symptoms: an overview for the practising clinician
- Combined C3b and Factor B Autoantibodies and MPGN Type II
- Primary cicatricial alopecia
- Ethanol Enhances Neurosteroidogenesis in Hippocampal Pyramidal Neurons by Paradoxical NMDA Receptor Activation
- Hair Loss in Women
- 5-Alpha Reductase Inhibitors and Erectile Dysfunction: The Connection
- Emerging medication for the treatment of male hypogonadism
- The Dark Side of 5α-Reductase Inhibitors' Therapy: Sexual Dysfunction, High Gleason Grade Prostate Cancer and Depression
- Frontal fibrosing alopecia: clinical and prognostic classification
- Steroid 5α-Reductase as a Novel Therapeutic Target for Schizophrenia and Other Neuropsychiatric Disorders
- Effects of 5-alpha reductase inhibitors on erectile function, sexual desire and ejaculation
- Sexual dysfunction in subjects treated with inhibitors of 5α-reductase for benign prostatic hyperplasia: a comprehensive review and meta-analysis
- 5alpha-reductase: history and clinical importance.
- Pattern Hair Loss in Men
- Effect of 5α-Reductase Inhibitors on Sexual Function: A Meta-Analysis and Systematic Review of Randomized Controlled Trials
- 5α-Reductase Type 2 Regulates Glucocorticoid Action and Metabolic Phenotype in Human Hepatocytes
- A review of the treatment of male pattern hair loss
- Androgens and hair loss
- Inhibitors of 5α-Reductase in the Treatment of Benign Prostatic Hyperplasia
- An update of anti-viral treatment of COVID-19
- Steroidal 5α-reductase and 17α-hydroxylase/17,20-lyase (CYP17) inhibitors useful in the treatment of prostatic diseases
- Hormonal Treatment Strategies Tailored to Non-Binary Transgender Individuals
- Anti‐androgens may protect against severe COVID‐19 outcomes: results from a prospective cohort study of 77 hospitalized men
- Actions of 5α-reductase inhibitors on the epididymis
- 5 Alpha-reductase inhibitors: whatʼs new?